Neoadjuvant Chemoradiation for Resectable Glioblastoma
Clinical trial NCT04209790 · TERMINATED
Trial details
- NCT number
- NCT04209790
- Sponsor
- Geisinger Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2022-09-14
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.